No Detail Found!

Fluoroquinolone Resistance in the Clinical Isolates of Kashmir Valley and In-Vitro Efficacy of Fosfomycin in Multiple Infections

Author(s)
Mehvish Saleem Transworld Muslim University Diagnostic Center,Srinagar, Jammu and Kashmir,India
Talat Masoodi Department of Microbiology, SKIMS Medical College,Srinagar, Jammu and Kashmir,India
Shaiqa Farooq Department of Microbiology, Government Medical College,Srinagar, Jammu and Kashmir,India
Betty Daniel Department of Botany, St. Josephs College & Research Center,Bangalore,India
Abstract
BACKGROUND: Antibacterial resistance is a major concern in healthcare associated infections. Longer hospital stay, empirical treatment without antimicrobial stewardship policy and ineffective infection control practices are making it difficult to treat infections. Kashmir valley lacks surveillance data and awareness about antibiotic resistance among clinicians, thus complicating patient care. The aim of this study was to investigate the prevalence of antibacterial resistance among various clinical isolates. METHODS: The study was conducted between February 2013 and April 2014 in the Srinagar city. Samples of urine, pus, and other body fluids (N=500) were examined for clinically important pathogens. Standard laboratory protocols were followed for the isolation, identification and susceptibility tests. Recent CLSI guidelines for antimicrobial susceptibility were followed using Kirby-Bauer method. RESULTS: Predominant pathogens identified in urine cultures were Escherichia coli (42.1%), Klebsiella pneumoniae (31.57%), Proteus species (7.8%), Pseudomonas aeruginosa (13.1%) and Enterococcus faecalis (5.26%). Methicillin resistant Staphylocoocus aureus (14.8%) and Methicillin sensitive Staphylococcus aureus (22.2%) were common isolates found in pus. Other frequent clinical isolates found in pus cultures were Proteus species (28.1%), Enterococcus faecalis (18.5%) and Pseudomonas aeruginosa (14.8%). Klebsiella pneumoniae and Staphylococcus aureus were prevalent isolates in semen cultures. All clinical isolates screened in this study were resistant to quinolones, aminoglycosides, cephalosporins, carbepenems and sulphonamides. Glycopeptide resistance was observed in one of the urinary isolates. All clinical isolates were sensitive to fosfomycin. CONCLUSION: We found high quinolone resistance in pathogens isolated from community acquired urinary tract infection (UTI) and nosocomial infections. Fosfomycin can be a good alternative choice in the treatment of urinary tract infection with greater efficacy & lesser antibiotic resistance. The drug has not been so far prescribed in routine clinical practice in the valley.
Publication Details
Page(s) 49-54
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 7, Issue: 4, Year: 2017

Request the full text from PASTIC

Keywords
Extended Spectrum Betalactamsaes, Antimicrobial resistance, Fluroquinolones, Urinary tract infection, Multidrug resistance, Surgical Site Infections
References
.2001 .WHO global strategy for the containment of antimicrobial resistance. , : .
Girou E,Rioux C,Brun-Buisson C,Lobel B. .2006 .The postoperative bacteriuria score: a new way to predict nosocomial infection after prostate surgery. Infect Control Hosp Epidemiol, 27(8) : 847-54.
.2010 .WHO Laboratory Manual for the Examination. Processing of Human Semen. 5th Edition, : .
. .Performance standards for antimicrobial susceptibility testing; 2010 eighteenth informational supplement M100-S18. , : .
Van der Mee-Marquet N,Savoyen P .2010 .CTX-M-type fluoroquinolone-resistant Escherichia coli: analysis of the colonization of residents and inanimate surfaces 1 year after a first case of urinary tract infection a nursing home in France. Infect Control Hosp Epidemiol, 31(9) : 968-70.
Rattanaumpawan P,Tolomeo P,Bilker WB,Fishman NO,Lautenbach E .2010 .Risk factors for fluoroquinolone resistance in Gram negative bacilli causing healthcareacquired urinary tract infections. J Hosp Infect, 76(4) : 324-7.
Alo Moses N,Ugah Uchenna I,Elom Michael O. Semen I .2013 .Culture: A Comparative Analysis between Solid Media and Liquid Media Supplementation. J Pharm Biol Sci, 5(5) : 67-72.
Fomda BA,Thokar MA,Khan A,Bhat JA .2014 .Nasal carriage of Methicillin-resistant Staphylococcus aureus among healthy population of Kashmir. Indian J Med Microbiol, 32(1) : 39-43.
Ena J,Dick RW,Jones RN,Wenzel RP .1993 .The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA, 269(5) : 598-602.
Tarai B,Das P,Kumar D,Physicians J Lab .2013 .Recurrent Challenges for Clinicians: Emergence of MethicillinResistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options. , 5(2) : 71-8.
Melzer M,Petersen I. .2007 .Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect, 55(3) : 254-9.
Rambabu V.,Rajasekhar K.,Kumar Reddy N. Dinesh,Kumar G. Santhosh .2015 .Study on Surgical Site Infections Caused By Esbl Producing Gram Negative Bacteria. Journal of Evidence based Medicine and Healthcare, 2(38) : 6092-6097.
Maraki S,Samonis G,Rafailidis PI,Vouloumanou EK,Mavromanolakis E,Falagas ME .2009 .Susceptibility of Urinary Tract Bacteria to Fosfomycin. , 53(10) : 4508-4510.
Tantry BA,Rahiman S. .2012 .Antibacterial resistance and trend of urinary tract pathogens to commonly used antibiotics in Kashmir Valley. West Indian Med, 61(7) : 703-7.
Patterson DL,Ko WC,Von Gottberg A .2001 .Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extendedspectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol, 39(6) : 2206-12.
Quale JM,Landman D,Bradford PA .2002 .Molecular epidemiology of a citywide outbreak of extendedspectrum b-lactamase-producing Klebsiella pneumoniae infection. Clin Infect Dis, 35(7) : 834-41.
Yigit H,Queenan AM,Anderson GJ .2001 .Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother, 45(4) : 1151-61.
Falagas ME,Kasiakou SK .2005 .Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis, 40(9) : 1333-41.
Collins VL,Marchaim D,Pogue JM,Moshos J,Bheemreddy S,Sunkara B .2012 .Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother, 56(4) : 2173-7.
Dalgic N,Sancar M,Bayraktar B,Dincer E,Pelit S .2011 .Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children. Scand J Infect Dis, 43(5) : 339-43.
.2009 .Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenemresistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep, 58(10) : 256-60.
Bleasdale SC,Trick WE,Gonzalez IM,Lyles RD,Hayden MK,Weinstein RA .2007 .Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med, 167(19) : 2073-9.
Borer A,Gilad J,Porat N,Megrelesvilli R,Saidel-Odes L,Peled N .2007 .Impact of 4% chlorhexidine wholebody washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect, 67(2) : 149-55.
Climo MW,Sepkowitz KA,Zuccotti G,Fraser VJ,Warren DK,Perl TM .2009 .The effect of daily bathing with chlorhexidine on the acquisition of methicillinresistant Staphylococcus aureus, vancomycin resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med, 37(6) : 1858-65.
0

Citations

0

Downloads

9

Views